Cyprodenate: Difference between revisions
Content deleted Content added
No edit summary |
populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot |
||
Line 1: | Line 1: | ||
{{ |
{{Drugbox |
||
⚫ | |||
⚫ | |||
| verifiedrevid = 443459701 |
| verifiedrevid = 443459701 |
||
| IUPAC_name = 2-dimethylaminoethyl 3-cyclohexylpropanoate |
| IUPAC_name = 2-dimethylaminoethyl 3-cyclohexylpropanoate |
||
| image=Cyprodenate.svg |
| image = Cyprodenate.svg |
||
| width= 200 |
| width = 200 |
||
<!--Clinical data--> |
|||
| tradename = |
|||
| Drugs.com = {{drugs.com|international|cyprodenate}} |
|||
⚫ | |||
<!--Identifiers--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 64892 |
| ChemSpiderID = 64892 |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Chemical data--> |
|||
⚫ | |||
⚫ | |||
| smiles = O=C(OCCN(C)C)CCC1CCCCC1 |
| smiles = O=C(OCCN(C)C)CCC1CCCCC1 |
||
⚫ | |||
| InChIKey = MPOYJPINNSIHAK-UHFFFAOYAN |
| InChIKey = MPOYJPINNSIHAK-UHFFFAOYAN |
||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
Line 15: | Line 32: | ||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = MPOYJPINNSIHAK-UHFFFAOYSA-N |
| StdInChIKey = MPOYJPINNSIHAK-UHFFFAOYSA-N |
||
⚫ | |||
⚫ | |||
| ATC_suffix= |
|||
⚫ | |||
⚫ | |||
| DrugBank= |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| bioavailability= |
|||
| metabolism = |
|||
| elimination_half-life= |
|||
| excretion = |
|||
| pregnancy_category = |
|||
| legal_status = |
|||
⚫ | |||
}} |
}} |
||
Revision as of 05:09, 2 September 2011
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.036.025 |
Chemical and physical data | |
Formula | C13H25NO2 |
Molar mass | 227.34 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cyprodenate (Actebral) is a stimulant drug.[1] It was used for counteracting the effects of benzodiazepine tranquillizer drugs before the development of newer antidotes such as flumazenil.[2] It produces dimethylethanolamine as a metabolite, and so might be expected to produce nootropic effects.
See also
References
- ^ Dormard Y, Levron JC, Le Fur JM. Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals. Arzneimittelforschung. 1975 Feb;25(2):201–7. PMID 1173033.
- ^ Bobkov IuG, Morozov IS. Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychostimulants. Biulleten Eksperimental'noi Biologii i Meditsiny. 1982 Oct;94(10):48–51. Russian. doi:10.1007/BF00827201. PMID 6129008.